nad has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gai, XL; Guo, L; Li, B; Quan, MY; Tan, GJ; Wang, JL; Wang, JQ; Xing, JN; Zhang, N | 1 |
1 other study(ies) available for nad and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
NAD+ attenuates experimental autoimmune encephalomyelitis through induction of CD11b+ gr-1+ myeloid-derived suppressor cells.
Topics: Animals; CD11b Antigen; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Mice; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Myeloid-Derived Suppressor Cells; NAD; Peptide Fragments; Phosphorylation; Receptors, Chemokine; STAT6 Transcription Factor | 2020 |